Apotex Bags First Biosimilar Neulasta, Plans To Undercut Amgen In Canada By 25%

 
• By Ian Schofield
  
Approved
Apotex has received approval in Canada for its biosimilar pegfilgrastim
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics